Evidence map›Paper›PMID 21549137›Full record

ReviewPhysiology & behavior2011

Neurobiology of aversive states.

Erin N Umberg, Emmanuel N Pothos

Abstract readReview
In one paragraph

Review in Physiology & behavior, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Aversive motivation and cognitive control.Neuroscience and biobehavioral reviews · 2022
    Review
  3. Article
  4. Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans.The Journal of clinical endocrinology and metabolism · 2015
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Erin N UmbergDepartment of Molecular Physiology and Pharmacology, Tufts University School of Medicine, Boston, MA 02111, United States.
Emmanuel N Pothos
Therapeutics Clinical Research · US

Funding

Effects of dietary obesity on midbrain dopamine systemsR01DK065872 · NIDDK · TUFTS UNIVERSITY BOSTON · PI POTHOS, EMMANUEL N · 2005 to 2009
$1.7M
CNS Dopamine as Marker for Obesity Predisposition: Link to Food and Drug RewardF31DA023760 · NIDA · TUFTS UNIVERSITY BOSTON · PI GEIGER, BRENDA · 2007 to 2010
$142k
NIDA NIH HHS F31 DA023760NIDA NIH HHS F31DA023760NIDDK NIH HHS 3R01DK065872NIDDK NIH HHS DK065872NIDDK NIH HHS R01 DK065872
6 · The paper itself

Abstract

Hoebel and colleagues are often known as students of reward and how it is coded in the CNS. This article, however, attempts to focus on the significant advances by Hoebel and others in dissecting out behavioral components of distinct aversive states and in understanding the neurobiology of aversion and the link between aversive states and addictive behaviors. Reward and aversion are not necessarily dichotomous and may reflect an affective continuum contingent upon environmental conditions. Descriptive and mechanistic studies pioneered by Bart Hoebel have demonstrated that the shift in the reward-aversion spectrum may be, in part, a result of changes in central dopamine/acetylcholine ratio, particularly in the nucleus accumbens. The path to aversion appears to include a specific neurochemical signature: reduced dopamine release and increased acetylcholine release in "reward centers" of the brain. Opioid receptors may have a neuromodulatory role on both of these neurotransmitters.

Indexed as

RewardAcetylcholineAnimalsAssociation LearningDopamineFood DeprivationNucleus AccumbensOpioid PeptidesAcetylcholineDopamineOpioid Peptides

Identifiers

PMID21549137
PMCPMC3116693
OpenAlexW2068976761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.